CC BY-NC-ND 4.0 · World J Nucl Med 2020; 19(02): 179
DOI: 10.4103/wjnm.WJNM_2_20
Letter to Editor

Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now

Jacques How
Division of Endocrinology, McGill University Health Center, Montreal, Quebec, Canada
,
Roger Tabah
1   Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada
,
Elliot Mitmaker
1   Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada
› Author Affiliations
 

#

Dear Editor,

We read with much interest the paper,[1] “Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience” by Kumar et al. published in the July–September 2019 issue of your journal. In April 2011, our team published our findings on this topic, at which time we suggested that this thyroid entity should be called “PETomas.”[2] We are, therefore, extremely surprised that Kumar et al. did not cite our publication and acknowledge our role in initiating the use of the term “PETomas.”

We would also like to draw the attention of your readers to a paper published in 2008 by Katz and Shaha of the Memorial Sloan-Kettering Cancer Center, wherein they proposed that this thyroid finding should be called “PET-associated incidental neoplasms (PAINS).”[3] Neither “PAINS” nor “PETomas” have thus far caught on in the literature so that we heartily welcome the usage of “PETomas” by Kumar et al. We believe that this term is simple and meaningful.


#

Conflict of Interest

There are no conflicts of interest.

Financial support and sponsorship

Nil.


  • References

  • 1 Kumar AA, Datta G, Singh H, Mukherjee PB, Vangal S. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience. World J Nucl Med 2019;18:273-82.
  • 2 Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: Clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011;54:83-8.
  • 3 Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;207:259-64.

Address for correspondence

Dr. Elliot J. Mitmaker
Department of Surgery, Section of Endocrine Surgery, McGill University Health Centre, Royal Victoria Hospital
Glen Site, 1001 Boul Decarie, Bureau D02.7324, Montréal, Québec H4A 3J1
Canada   

Publication History

Received: 05 January 2020

Accepted: 23 January 2020

Article published online:
19 April 2022

© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Kumar AA, Datta G, Singh H, Mukherjee PB, Vangal S. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience. World J Nucl Med 2019;18:273-82.
  • 2 Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: Clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011;54:83-8.
  • 3 Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;207:259-64.